Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2020-04-17 Capital/Financing Update
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Subscription Right Plan 2020_BoD Report_7_180-7_191_D_for website.pdf
Capital/Financing Update Classification · 95% confidence The document is titled "Bijzonder verslag van de raad van bestuur overeenkomstig artikelen 7:180 en 7:191 van het Wetboek van Vennootschappen en Verenigingen" (Special report of the board of directors pursuant to articles 7:180 and 7:191 of the Code of Companies and Associations). It explicitly discusses the proposed issuance of subscription rights (Inschrijvingsrechten) to personnel and the cancellation of pre-emptive rights for existing shareholders. This type of detailed report, mandated by specific articles of the Belgian corporate law (WVV) to justify capital structure changes affecting shareholder rights, aligns best with documents related to capital structure or financing activities, but more specifically, it is a formal report justifying a corporate action. Given the options, this document details a capital/financing activity (issuance of rights) and is a formal report justifying the action, including analysis of dilution and shareholder rights. It is not a standard 10-K, ER, or IR. It is a specific report justifying the cancellation of pre-emptive rights for a share incentive plan. This fits best under Capital/Financing Update (CAP) as it details the issuance of rights and capital structure changes, or potentially a Regulatory Filing (RNS) if no better fit exists. However, since it is a detailed, legally required report justifying a specific capital action (issuance of subscription rights and cancellation of pre-emptive rights), 'CAP' (Capital/Financing Update) is the most appropriate category describing the core subject matter, even though it is structured as a formal report. Reviewing the definitions: - CAP: Updates on company fundraising, financing activities, or capital structure changes. This document is entirely about issuing new instruments (subscription rights) that lead to potential capital changes, justifying the removal of pre-emptive rights. This is a strong fit. - LTR: Legal Proceedings Report (No). - DVA: Declaration of Voting Results (No, it precedes the vote). - SHA: Share Issue/Capital Change (This is related, but CAP covers the broader financing/capital structure justification). Since the document is a comprehensive report detailing the terms and justification for issuing instruments that change the capital structure, CAP is the most precise fit among the provided codes for this type of corporate action disclosure.
2020-04-17 Dutch
Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetings
AGM Information Classification · 98% confidence The document is an 'Important update to Galapagos' invitation to its ordinary and extraordinary shareholders' meetings' scheduled for April 28, 2020. It details procedural changes (holding meetings behind closed doors, voting by proxy/form only) due to the COVID-19 pandemic. This content directly relates to the arrangements and logistics for the Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R). Although it is an update, the core subject matter is the meeting itself, making AGM-R more specific than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2020-04-17 English
Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetings
AGM Information Classification · 98% confidence The document is titled "Belangrijke update over de uitnodiging tot de gewone en buitengewone algemene vergaderingen van Galapagos" (Important update regarding the invitation to the ordinary and extraordinary general meetings of Galapagos). It explicitly discusses arrangements for the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM), such as holding them behind closed doors, proxy voting procedures, and deadlines for submitting forms. This content directly relates to the preparation, announcement, and logistics surrounding the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R).
2020-04-17 Dutch
6-K Filing
Regulatory Filings
2020-04-17 English
6-K Filing
Regulatory Filings
2020-04-17 English
6-K Filing
Regulatory Filings
2020-04-16 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.